• Home
  • EMCrit-RACC
  • PulmCrit
  • IBCC
  • EMNerd
  • Tox & Hound
  • About
    • About EMCrit
    • About PulmCrit
    • EMCrit FAQ
    • Subscription Options
  • Contact Us

PulmCrit (EMCrit)

Online Medical Education on Emergency Department (ED) Critical Care, Trauma, and Resuscitation

  • About PulmCrit
  • Genius General Hospital
  • PulmCrit TOC
  • IBCC TOC
  • IBCC Podcast
You are here: Home / Archives for PULMCrit

PulmCrit – RECOVERY confirms benefit of toci combined with dexamethasone

February 12, 2021 by Josh Farkas 14 Comments

The RECOVERY trial just released a preprint demonstrating benefit from tocilizumab in COVID-19.  As with the prior RECOVERY studies, this is a multicenter, open-label, pragmatic trial.  A robust mortality benefit was detected (the fragility index calculates to 17, which isn’t too shabby).  Several important secondary endpoints were positive as well (e.g., reduced intubation rate, reduced […]

IBCC chapter & cast – Atrial Fibrillation in critical illness

February 8, 2021 by Josh Farkas 6 Comments

Most available data on atrial fibrillation pertains to chronic outpatient management or atrial fibrillation following cardiac surgery.  This data may not apply perfectly to most critically ill patients.  Extrapolation of available data to the management of critically ill patient is challenging, with much left to clinical judgement. The IBCC chapter is located 👉 here. The […]

PulmCrit Wee – MENDS2: Fentanyl or fentanyl for sedation in mechanically ventilated adults with sepsis

February 2, 2021 by Josh Farkas 1 Comment

The MENDS2 trial was intended as a study comparing dexmedetomidine to propofol. However, the doses of these medications used in the study weren’t high enough to be impactful. In retrospect, the study may actually be an investigation of how clinicians approach the agitated intubated patient – potentially revealing an over-reliance on opioid infusions.

PulmCrit Wee – Follow-up Bamlanivimab study unmasks statistical chicanery

January 26, 2021 by Josh Farkas 2 Comments

Whether or not you have any interest in bamlanivimab, you should read this post as an amusing example of shoddy statistics being published in top journals.  background & general landscape of the two trials The BLAZE-1 trial involved randomizing patients within three days of testing positive for COVID-19 to one of four arms:  placebo, 700 […]

IBCC – Revamped COVID chapter focusing on ICU & stepdown management

January 25, 2021 by Josh Farkas 4 Comments

The COVID chapter has been updated, overhauled, and refocused on the management of the sickest COVID patients (those requiring admission to ICU or stepdown units).  The new chapter removes more basic information about COVID that we’re all probably familiar with at this point (but the original, larger chapter is still available here). The goal of […]

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 85
  • Next Page »

Follow EMCrit Everywhere

Click for More Subscribe Options


Other Stuff

  • Have a great idea for the next podcast? Share it here!
  • Tough Questions. Maybe you have an answer!
  • When you're done listening to the podcast,
    check out these great sites.

Who We Are

We are the EMCrit Project, a team of independent medical bloggers and podcasters joined together by our common love of cutting-edge care, iconoclastic ramblings, and FOAM.

Like Us on Facebook

Like Us on Facebook

Subscribe by Email

EMCrit is a trademark of Metasin LLC. Copyright 2009-. This site represents our opinions only. See our full disclaimer, our privacy policy, commenting policy and here for credits and attribution.